Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals
Juan Berenguer(Instituto de Salud Carlos III), Juan González‐García(Hospital Universitario La Paz), Ángela Gil‐Martin(Madrid Health Service), Marisa Montes(Hospital La Paz Institute for Health Research), Ignacio de los Santos, Maria Clara Costa Calvo(Universidad del Zulia), Inmaculada Jarrín, Jesús Troya(Hospital Universitario Infanta Leonor), Juan Emilio Losa, Teresa Aldámiz‐Echevarría(Hospital General Universitario Gregorio Marañón), María Teresa de Guzmán(Hospital Universitario Infanta Cristina), Lourdes Domínguez(Hospital Universitario 12 De Octubre), María Jesús Téllez(Hospital Clínico San Carlos), Regino Serrano(Hospital Universitario del Henares)
Cited by 58
Related Papers
Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
|International Journal of Reproductive Medicine|2014|451
Autologous hematopoietic stem cell transplantation in multiple sclerosis
|Neurology|2015|247
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137
Efficacy of senna versus lactulose in terminal cancer patients treated with opioids
|Journal of Pain and Symptom Management|1998|95